These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 9818624

  • 21. Reboxetine: its effects as measured by the Social Adaptation Self-evaluation Scale.
    Healy D.
    Acta Psychiatr Scand Suppl; 2000; 402():45-51. PubMed ID: 10901159
    [Abstract] [Full Text] [Related]

  • 22. Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine: a review.
    Burrows GD, Maguire KP, Norman TR.
    J Clin Psychiatry; 1998; 59 Suppl 14():4-7. PubMed ID: 9818623
    [Abstract] [Full Text] [Related]

  • 23. A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
    Papakostas GI, Nelson JC, Kasper S, Möller HJ.
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):122-7. PubMed ID: 17719752
    [Abstract] [Full Text] [Related]

  • 24. Effect of reboxetine on depression in Parkinson's disease patients.
    Lemke MR.
    J Clin Psychiatry; 2002 Apr; 63(4):300-4. PubMed ID: 12000202
    [Abstract] [Full Text] [Related]

  • 25. The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study.
    Dannon PN, Iancu I, Grunhaus L.
    Hum Psychopharmacol; 2002 Oct; 17(7):329-33. PubMed ID: 12415550
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ, Hu WH, Chen CC, Hsiao CC, Tsai SJ, Ruwe FJ.
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effects of antidepressants on psychomotor function with particular reference to reboxetine.
    Hindmarch I.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S17-21; discussion S71-3. PubMed ID: 9169307
    [Abstract] [Full Text] [Related]

  • 30. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
    McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF.
    Am J Psychiatry; 2000 Mar; 157(3):344-50. PubMed ID: 10698808
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Predicting response: noradrenaline reuptake inhibition.
    Montgomery SA.
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 1():S21-6. PubMed ID: 10468325
    [Abstract] [Full Text] [Related]

  • 34. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
    Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, Kerekes MF, Gerken M, Wieseler B.
    BMJ; 2010 Oct 12; 341():c4737. PubMed ID: 20940209
    [Abstract] [Full Text] [Related]

  • 35. Role of serotonin and noradrenaline in social dysfunction: a review of data on reboxetine and the Social Adaptation Self-evaluation Scale (SASS).
    Keller M.
    Gen Hosp Psychiatry; 2001 Oct 12; 23(1):15-9. PubMed ID: 11226552
    [Abstract] [Full Text] [Related]

  • 36. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis.
    Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D.
    J Psychiatr Res; 2009 May 12; 43(8):792-7. PubMed ID: 19230909
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patients.
    Versiani M.
    Int J Psychiatry Clin Pract; 2000 May 12; 4(3):201-8. PubMed ID: 24927454
    [Abstract] [Full Text] [Related]

  • 40. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
    Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G.
    Am J Psychiatry; 2004 Oct 12; 161(10):1864-71. PubMed ID: 15465984
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.